These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11906747)

  • 1. The legacy of nuclear risk and the founder effect in biotechnology organizations.
    Fleising U
    Trends Biotechnol; 2002 Apr; 20(4):156-9. PubMed ID: 11906747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ImClone's failed culture of expertise.
    Fleising U
    Trends Biotechnol; 2002 Aug; 20(8):326. PubMed ID: 12127277
    [No Abstract]   [Full Text] [Related]  

  • 3. From 'trust us' to participatory governance: Deliberative publics and science policy.
    Burgess MM
    Public Underst Sci; 2014 Jan; 23(1):48-52. PubMed ID: 24434712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert discourses of risk and ethics on genetically manipulated organisms: the weaving of public alienation.
    Wynne B
    Not Polit; 2001; 17(62):51-76. PubMed ID: 15468486
    [No Abstract]   [Full Text] [Related]  

  • 5. BIO reaches adolescence.
    Fox JL
    Nat Biotechnol; 2006 Apr; 24(4):381-3. PubMed ID: 16601712
    [No Abstract]   [Full Text] [Related]  

  • 6. Attitudes toward biotechnology in the European Union.
    Pardo R; Midden C; Miller JD
    J Biotechnol; 2002 Sep; 98(1):9-24. PubMed ID: 12126802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Europe ambivalent on biotechnology. Biotechnology and the European Public Concerted Action group.
    Nature; 1997 Jun; 387(6636):845-7. PubMed ID: 9202112
    [No Abstract]   [Full Text] [Related]  

  • 8. The governance of human genetics: policy discourse and constructions of public trust.
    Jones M; Salter B
    New Genet Soc; 2003 Apr; 22(1):21-41. PubMed ID: 15282897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biomedical industry and the need for tort reform.
    Saha S; Saha P
    IEEE Eng Med Biol Mag; 2003; 22(4):154-5. PubMed ID: 14515709
    [No Abstract]   [Full Text] [Related]  

  • 10. Science and society.
    May RM
    Science; 2001 May; 292(5519):1021. PubMed ID: 11352032
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of biotechnology by executive orders: questions about constitutionality, legality and overall fairness to the American public.
    Cuomo P
    J Biolaw Bus; 2005; 8(2):30-42. PubMed ID: 16538813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number crunching.
    Nat Biotechnol; 2003 Aug; 21(8):831. PubMed ID: 12894180
    [No Abstract]   [Full Text] [Related]  

  • 13. Democracy unleashed--unpacking the tooth fairy in drug industry R&D.
    Ozdemir V; Williams-Jones B
    Nat Biotechnol; 2006 Nov; 24(11):1324-6; author reply 1326-7. PubMed ID: 17093467
    [No Abstract]   [Full Text] [Related]  

  • 14. Britain opens biotech regulation to greater public involvement.
    Masood E
    Nature; 1999 May; 399(6734):287-8. PubMed ID: 10360555
    [No Abstract]   [Full Text] [Related]  

  • 15. Nuclear medicine technology state of the union.
    Mehlburg L
    J Nucl Med Technol; 2003 Dec; 31(4):190. PubMed ID: 14657283
    [No Abstract]   [Full Text] [Related]  

  • 16. Needed: a modest proposal.
    Schmidt H
    Hastings Cent Rep; 2007; 37(6):6; author reply 10-1. PubMed ID: 18179094
    [No Abstract]   [Full Text] [Related]  

  • 17. Scientific Citizenship and good governance: implications for biotechnology.
    Davies KG; Wolf-Phillips J
    Trends Biotechnol; 2006 Feb; 24(2):57-61. PubMed ID: 16380180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-existence of agricultural production systems.
    Jank B; Rath J; Gaugitsch H
    Trends Biotechnol; 2006 May; 24(5):198-200. PubMed ID: 16545877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future direction of Australian biotechnology. The report of the Biotechnology Consultative Group.
    Aust J Biotechnol; 1988 Sep; 2(2):103-5. PubMed ID: 2485321
    [No Abstract]   [Full Text] [Related]  

  • 20. No exit and the organization of voice in biotechnology and pharmaceuticals.
    Light DW; Castellblanch R; Arredondo P; Socolar D
    J Health Polit Policy Law; 2003; 28(2-3):473-507. PubMed ID: 12836894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.